
Acumen Pharmaceuticals (ABOS) PEG Ratio
Market Cap: $61.78M
Avg Volume: 235.07K
Industry: Biotechnology
Sector: Healthcare
PEG Ratio Summary
- Acumen Pharmaceuticals's trailing twelve month (TTM) PEG ratio is 0.02.
- Acumen Pharmaceuticals's annual PEG ratio as of today is -0.02.
- Acumen Pharmaceuticals's quarterly PEG ratio is -0.03.
What is the PEG Ratio?
The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.
How is the PEG Ratio calculated?
The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:
PEG Ratio = (P/E Ratio) / (EPS Growth Rate)
This helps investors to determine a stock's value while considering the company's earnings growth.
Related Metrics
Other important metrics to assess Acumen Pharmaceuticals's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -1.01
- Quarterly: -0.69
- TTM: -0.60
- P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
- Annual: 0.00
- Quarterly: 0.00
- TTM: 0.00
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 0.57
- Quarterly: 0.57
- TTM: 0.34
- P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -1.20
- Quarterly: -3.79
- TTM: -0.71
These metrics provide insights into Acumen Pharmaceuticals's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
TTM PEG Ratio
0.02
Annual PEG Ratio
-0.02
Quarterly PEG Ratio
-0.03
Acumen Pharmaceuticals Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio
Acumen Pharmaceuticals Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
Year | PEG Ratio | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
---|---|---|---|---|---|
2024 | -0.02 | -1.01 | 0.00 | 0.57 | -1.20 |
2023 | -0.44 | -3.56 | 0.00 | 0.70 | -4.32 |
2022 | 0.07 | -5.42 | 0.00 | 1.16 | -6.24 |
2021 | 0.00 | -1.51 | 0.00 | 1.22 | -15.23 |
2020 | 11.02 | -110.19 | 562.01 | -43.41 | -108.33 |
2019 | 0.00 | -102.65 | 475.58 | -70.67 | -118.37 |
Related Metrics
Explore detailed financial metrics and analysis for ABOS.